feed,title,long_url,short_url
Benzinga,"With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023",https://benzinga.com/analyst-ratings/analyst-color/23/04/31961584/with-fda-submission-for-sickle-cell-gene-therapy-bluebird-bio-can-potentially-have-,https://da.gd/346eN0
Benzinga,ChatGPT On Steroids? Why Auto-GPT Is The Next Big Thing In AI,https://benzinga.com/startups/23/04/31965063/chatgpt-on-steroids-why-auto-gpt-is-the-next-big-thing-in-ai,https://da.gd/2dyDlY
